Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abivax SA - American Depositary Shares (NQ:ABVX)

144.30 +0.31 (+0.22%)

Streaming Delayed Price Updated: 1:33 PM EDT, Jul 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	741,022
Open	142.50
Bid (Size)	144.24 (200)
Ask (Size)	144.38 (100)
Prev. Close	143.99
Today's Range	140.56 - 145.01
52wk Range	7.700 - 148.83
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Abivax: Wall Street Catches Up to the Data ↗

Today 12:25 EDT

Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underwriters fully exercised, signaling strong institutional...

Via MarketBeat

Abivax Announces Closing of $920 Million Public Offering

July 06, 2026

From Abivax

Via GlobeNewswire

Performance

YTD	+7.9%	+7.9%
1 Month	+42.1%	+42.1%
3 Month	+20.8%	+20.8%
6 Month	+17.1%	+17.1%
1 Year	+1715.1%	+1715.1%

More News

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

July 02, 2026

From Abivax

Via GlobeNewswire

Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

July 01, 2026

From Abivax

Via GlobeNewswire

Abivax announces trading resumption of its ordinary shares on Euronext Paris

July 01, 2026

From Abivax

Via GlobeNewswire

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

July 01, 2026

From Abivax

Via GlobeNewswire

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

July 01, 2026

From Abivax

Via GlobeNewswire

Abivax Announces Launch of Public Offering of American Depositary Shares

June 30, 2026

From Abivax

Via GlobeNewswire

Here are the top movers in Tuesday's session. ↗

June 30, 2026

Via Chartmill

Top movers analysis in the middle of the day on 2026-06-30: top gainers and losers in today's session. ↗

June 30, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

June 30, 2026

Via Chartmill

Tuesday's pre-market session: top gainers and losers ↗

June 30, 2026

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 30, 2026

Via Benzinga

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

June 29, 2026

From Abivax

Via GlobeNewswire

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm

June 17, 2026

From Schall Law

Via GlobeNewswire

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm

June 10, 2026

From Schall Law

Via GlobeNewswire

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm

June 03, 2026

From The Schall Law Firm

Via Business Wire

This Stock Is Up 1,000% Over the Past Year. Is There More Upside Ahead? ↗

June 03, 2026

Via The Motley Fool

Keep an eye on the top gainers and losers in Tuesday's session. ↗

June 02, 2026

Via Chartmill

These stocks are moving in today's session ↗

June 02, 2026

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

June 02, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

June 02, 2026

Via Chartmill

Which stocks are moving after the closing bell on Monday? ↗

June 01, 2026

Via Chartmill

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

June 01, 2026

From Abivax

Via GlobeNewswire

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

May 22, 2026

From Abivax

Via GlobeNewswire

Frequently Asked Questions

Is Abivax SA - American Depositary Shares publicly traded?

Yes, Abivax SA - American Depositary Shares is publicly traded.

What exchange does Abivax SA - American Depositary Shares trade on?

Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Abivax SA - American Depositary Shares?

The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market

What is the current price of Abivax SA - American Depositary Shares?

The current price of Abivax SA - American Depositary Shares is 144.30

When was Abivax SA - American Depositary Shares last traded?

The last trade of Abivax SA - American Depositary Shares was at 07/07/26 01:33 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.